Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020

References

• Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845.
   PubMed Web of Science ®Google Scholar
• Sauteur PM M, Jacobs BC, Spuesens EB, et al. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis. PLoS Pathog. 2014;10(6):e1003983.
   PubMed Web of Science ®Google Scholar
• Xiao L, Ptacek T, Osborne JD, et al. Comparative genome analysis of Mycoplasma pneumoniae. BMC Genomics. 2015;16(1):1–16.
   PubMed Web of Science ®Google Scholar
• Jacobs E, Ehrhardt I, Dumke R. New insights in the outbreak pattern of Mycoplasma pneumoniae. Int J Med Microbiol. 2015;305(7):705–708.
   PubMed Web of Science ®Google Scholar
• Bajantri B, Venkatram S, Diaz-Fuentes G. Mycoplasma pneumoniae: a potentially severe infection. J Clin Med Res. 2018;10(7):535–544.
   PubMedGoogle Scholar
• Song JH, Oh WS, Kang CI, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107–114.
   PubMed Web of Science ®Google Scholar
• Zhu YG, Tang XD, Lu YT, et al. Contemporary situation of community-acquired pneumonia in China: a systematic review. J Transl Int Med. 2018;6(1):26–31.
   PubMed Web of Science ®Google Scholar
• Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010;16(3):162–169.
   PubMed Web of Science ®Google Scholar
• Narita M. Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol. 2016;7(1):23–31.
   PubMedGoogle Scholar
• Sauteur PM M, Huizinga R, Tio-Gillen AP, et al. Intrathecal antibody responses to GalC in Guillain–Barré syndrome triggered by Mycoplasma pneumoniae. J Neuroimmunol. 2018;314:13–16.
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Wang YC, Hsu WH, et al. Incident asthma and Mycoplasma pneumoniae: a nationwide cohort study. J Allergy Clin Immunol. 2016;137(4):1017–1023. e6.
   PubMed Web of Science ®Google Scholar
• Sauteur PM M, Theiler M, Buettcher M, et al. Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia. JAMA Dermatol. 2020;156(2):144–150.
   PubMed Web of Science ®Google Scholar
• Watkins L, Olson D, Diaz MH, et al. Epidemiology and molecular characteristics of Mycoplasma pneumoniae during an outbreak of M. pneumoniae-associated Stevens–Johnson syndrome. Pediatr Infect Dis J. 2017;36(6):564–571.
   PubMed Web of Science ®Google Scholar
• Cao B, Qu JX, Yin YD, et al. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Clin Respir J. 2017;11(4):419–429.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Oishi T, Miyata I, et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008–2015. Emerg Infect Dis. 2017;23(10):1703–1706.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48(12):4624–4630.
   PubMed Web of Science ®Google Scholar
• Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother. 2005;49(6):2302–2306.
   PubMed Web of Science ®Google Scholar
• Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45(8):617–620.
   PubMed Web of Science ®Google Scholar
• Cardinale F, Chironna M, Dumke R, et al. Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia. Eur Respir J. 2011;37(6):1522–1524.
   PubMed Web of Science ®Google Scholar
• Loconsole D, De Robertis AL, Sallustio A, et al. Update on the epidemiology of macrolide-resistant Mycoplasma pneumoniae in Europe: a systematic review. Infect Dis Rep. 2021;13(3):811–820.
   PubMed Web of Science ®Google Scholar
• Oishi T, Takahashi K, Wakabayashi S, et al. Comparing antimicrobial susceptibilities among Mycoplasma pneumoniae isolates from pediatric patients in Japan between two recent epidemic periods. Antimicrob Agents Chemother. 2019;63(7):e02517–18.
   PubMed Web of Science ®Google Scholar
• Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57(3):1521–1523.
   PubMed Web of Science ®Google Scholar
• Zhao F, Liu J, Shi W, et al. Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016. Antimicrob Resist Infect Control. 2019;8:18.
   PubMed Web of Science ®Google Scholar
• Lee H, Yun KW, Lee HJ, et al. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018;16(1):23–34.
   PubMed Web of Science ®Google Scholar
• Zhao F, Li J, Liu J, et al. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China. Antimicrob Resist Infect Control. 2019;8:143.
   PubMed Web of Science ®Google Scholar
• Guo DX, Hu WJ, Wei R, et al. Epidemiology and mechanism of drug resistance of Mycoplasma pneumoniae in Beijing, China: a multicenter study. Bosn J Basic Med Sci. 2019;19(3):288–296.
   PubMed Web of Science ®Google Scholar
• Shi WX, Wu SS, Gong C, et al. The epidemiological characteristics and drug resistance of Mycoplasma pneumoniae in patients with community-acquired pneumonia during 2011–2015 in 5 sentinel hospitals in Beijing. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(9):832–836.
   PubMedGoogle Scholar
• Respiratory Society of Chinese Medical Association. Guidelines for the diagnosis and treatment of community-acquired pneumonia in Chinese adults (2016 edition). Chinese J Tuberculosis Respir Dis. 2016;39(4):253–279.
   Google Scholar
• Respiratory Group. Pediatrics Society of Chinese Medical Association, Editorial Committee of Chinese Journal of Pediatrics. Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I). Chinese J Pediatr. 2013;51(10):745–752.
   Google Scholar
• Respiratory Group. Pediatrics Society of Chinese Medical Association, Editorial Committee of Chinese Journal of Pediatrics. Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (II). Chinese J Pediatr. 2013;51(11):856–862.
   Google Scholar
• Gong C, Zhang T, Luo M, et al. Distribution of the atypical pathogens of community-acquired pneumonia to disease severity. J Thorac Dis. 2018;10(11):5991–6001.
   PubMed Web of Science ®Google Scholar
• Zhao F, Liu L, Tao X, et al. Culture-independent detection and genotyping of Mycoplasma pneumoniae in clinical specimens from Beijing, China. PLoS One. 2015;10(10):e0141702.
   PubMed Web of Science ®Google Scholar
• Lenglet A, Herrador Z, Magiorakos AP, et al. European working group on Mycoplasma pneumoniae surveillance. surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. Euro Surveill. 2012;17(5):20075.
   PubMedGoogle Scholar
• Dong M, Luo M, Li A, et al. Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: a large-scale active surveillance study. J Infect. 2021;83(5):607–635.
   PubMed Web of Science ®Google Scholar
• Chalker V, Stocki T, Litt D, et al. Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012. Euro Surveill. 2012;17(6):20081.
   PubMedGoogle Scholar
• Prince OA, Krunkosky TM, Krause DC. In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium. Infect Immun. 2014;82(2):579–586.
   PubMed Web of Science ®Google Scholar
• Bose S, Segovia JA, Somarajan SR, et al. ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity. mBio. 2014;5(6):e02186–14.
   PubMed Web of Science ®Google Scholar
• Xing Q, Li G, Xing Y, et al. Precautions are Needed for COVID-19 Patients with Coinfection of Common Respiratory Pathogens. medRxiv. 2020:2020.02.29.20027698-20027698.
   PubMedGoogle Scholar
• Editorial Committee of Respiratory Group. Pediatrics branch of Chinese Medical Association, Chinese Clinical Journal of Practical Pediatrics. Expert consensus on diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2015 edition). Chinese J Appl Clin Pediatr. 2015;30(17):1034.
   Google Scholar
• NHC. Guiding Principles of Clinical Application of Antibiotics (Edition 2015). Beijing: National Health Commission of the People’s Republic of China. Beijing; 2015; http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id = c18e1014de6c45ed9f6f9d592b43db42.
   Google Scholar